Due to COVID-19, new study enrollment is being assessed on a case by case basis. If you have any questions please call our central phone number at 616-391-1230.
Protocol | Alliance A071601 |
---|---|
Cancer Type: | CRANIOPHARYNGIOMAS |
Fast Facts |
Phase II Trial of BRAF/MEK Inhibitors in Papillary Craniopharyngiomas
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG BN007 |
---|---|
Cancer Type: | Unmethylated Glioblastoma |
Fast Facts |
A Randomized Phase II/III Open-Label Study of Ipilimumab and Nivolumab Versus Temozolomide in Patients With Newly Diagnosed MGMT (Tumor O-6-Methylguanine DNA Methyltransferase) Unmethylated Glioblastoma
Protocol | Alliance A071702 |
---|---|
Cancer Type: | Recurrent Glioblastoma |
Fast Facts |
A Phase II Study of Checkpoint Blockade Immunotherapy in Patients with Somatically Hypermutated Recurrent Glioblastoma
Protocol | NRG BN011 |
---|---|
Cancer Type: | Methylated MGMT Promoter Glioblastoma |
Fast Facts |
A Phase III Trial of Lomustine-Temozolomide Combination Therapy Versus Standard Temozolomide in Patients with Methylated MGMT Promoter Glioblastoma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | N0577 |
---|---|
Cancer Type: | Codeleted Anaplastic Glioma |
Fast Facts |
Phase III Intergroup Study of Radiotherapy versus Temozolomide Alone versus Radiotherapy with Concomitant and Adjuvant Temozolomide for Patients with 1p/19q Codeleted Anaplastic Glioma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A071401 |
---|---|
Cancer Type: | MENINGIOMAS WITH SMO/AKT/NF2 MUTATIONS |
Fast Facts |
Phase II Trial of SMO/AKT/NF2 Inhibitors in Progressive Meningiomas With SMO/AKT/NF2 Mutations
Protocol | NRG BN003 |
---|---|
Cancer Type: | MENINGIOMA |
Fast Facts |
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A071701 |
---|---|
Cancer Type: | Brain metastases |
Fast Facts |
Genomically-Guided Treatment Trial in Brain Metastases
Protocol | Alliance A071801 |
---|---|
Cancer Type: | Metastatic Brain Disease |
Fast Facts |
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared with Fractionated SRS (FSRS) for Resected Metastatic Brain Disease
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | WF 1801 |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | AFT-25 COMET |
---|---|
Cancer Type: | Low Risk DCIS |
Fast Facts |
Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial for Low Risk DCIS: A Phase III Prospective Randomized Trial
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA1181 |
---|---|
Cancer Type: | Neoadjuvant Breast |
Fast Facts |
Preoperative THP and postoperative HP in patients who achieve a pathologic complete response
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1706 |
---|---|
Cancer Type: | Inflammatory Breast Cancer |
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently with Radiotherapy versus Radiotherapy Alone for Inflammatory Breast Cancer
Protocol | Alliance A011801 |
---|---|
Cancer Type: | HER2 positive Breast Cancer |
The COMPASSHER2 Trials (COMprehensive Use of Pathologic Response ASSessment to Optimize Therapy in HER2-Positive Breast Cancer): COMPASSHER2 Residual Disease (RD), A Double-Blinded, Phase III Randomized Trial of T-DM1 and Placebo Compared with T-DM1 and Tucatinib
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | CCTG MA.39 Adjuvant |
---|---|
Cancer Type: | LOW RISK NODE POSITIVE BREAST CANCER |
Fast Facts |
TAILOR RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
Protocol | NRG BR007 |
---|---|
Cancer Type: | Stage 1, Hormone Sensitive Her2 negative |
Fast Facts |
Phase III Clinical Trial Evaluating De-Escalation of Breast Radiation for Conservative Treatment of Stage 1, Hormone Sensitive HER2-Negative, Oncotype Recurrence Score < 18 Breast Cancer (DEBRA) De-Escalation of Breast Radiation
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S2007 |
---|---|
Cancer Type: | HER2-Negative Breast Cancer |
Fast Facts |
A Phase II Trial of Sacituzumab Govitecan for Patients with HER2-Negative Breast Cancer and Brain Metastases
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | PDM 9846 |
---|---|
Cancer Type: | Tissue Procurement |
Fast Facts |
Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1501 CC cardiac tox |
---|---|
Cancer Type: | METASTATIC HER-2+ BREAST CANCER |
Fast Facts |
Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients With Metastatic HER-2+ Breast Cancer, Phase III
Protocol | SWOG S1703 |
---|---|
Cancer Type: | METASTATIC BREAST CANCER |
Fast Facts |
Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored With Serum Tumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients With Metastatic Hormone Receptor Positive HER-2 Negative Breast Cancer
Protocol | URCC 16070 CC nausea |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
Treatment of Refractory Nausea
Protocol | URCC 18007 |
---|---|
Cancer Type: | Cancer-Related Fatigue |
Fast Facts |
Randomized Placebo-Controlled Trial of Bupropion for Cancer-Related Fatigue
Protocol | URCC 19085 |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
Wireless Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy-Induced Peripheral Neuropathy: A Phase II Clinical Trial
Protocol | Alliance A231901CD |
---|---|
Cancer Type: | CCDR |
Fast Facts |
IMPROVING PATIENT-CENTERED COMMUNICATION IN BREAST CANCER: A RCT OF A SHARED DECISION ENGAGEMENT SYSTEM (SHARES)
Protocol | Alliance A191901 |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA1151 (TMIST) |
---|---|
Cancer Type: | Screening |
Fast Facts |
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A231901CD |
---|---|
Cancer Type: | CCDR |
Fast Facts |
IMPROVING PATIENT-CENTERED COMMUNICATION IN BREAST CANCER: A RCT OF A SHARED DECISION ENGAGEMENT SYSTEM (SHARES)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1912CD |
---|---|
Cancer Type: | CCDR |
Fast Facts |
A RANDOMIZED TRIAL ADDRESSING CANCER-RELATED FINANCIAL HARDSHIP THROUGH
DELIVERY OF A PROACTIVE FINANCIAL NAVIGATION INTERVENTION (CREDIT)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG CC007CD |
---|---|
Cancer Type: | Prostate Cancer |
Fast Facts |
Increasing the Dose of Survivorship Care Planning In Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy
Protocol | Alliance A231601CD |
---|---|
Cancer Type: | CCDR |
Fast Facts |
Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | PDM 9846 |
---|---|
Cancer Type: | Tissue Procurement |
Fast Facts |
Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | WF 1801 |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1501 CC cardiac tox |
---|---|
Cancer Type: | METASTATIC HER-2+ BREAST CANCER |
Fast Facts |
Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients With Metastatic HER-2+ Breast Cancer, Phase III
Protocol | SWOG S1703 |
---|---|
Cancer Type: | METASTATIC BREAST CANCER |
Fast Facts |
Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored With Serum Tumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients With Metastatic Hormone Receptor Positive HER-2 Negative Breast Cancer
Protocol | URCC 16070 CC nausea |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
Treatment of Refractory Nausea
Protocol | URCC 18007 |
---|---|
Cancer Type: | Cancer-Related Fatigue |
Fast Facts |
Randomized Placebo-Controlled Trial of Bupropion for Cancer-Related Fatigue
Protocol | URCC 19085 |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
Wireless Transcutaneous Electrical Nerve Stimulation (TENS) for Chemotherapy-Induced Peripheral Neuropathy: A Phase II Clinical Trial
Protocol | SWOG S1904 |
---|---|
Cancer Type: | ATYPICAL HYPERPLASIA OR LOBULAR CARCINOMA IN SITU |
Fast Facts |
CLUSTER RANDOMIZED CONTROLLED TRIAL OF PATIENT AND PROVIDER DECISION SUPPORT TO INCREASE CHEMOPREVENTION INFORMED CHOICE AMONG WOMEN WITH
ATYPICAL HYPERPLASIA OR LOBULAR CARCINOMA IN SITU - MAKING INFORMED CHOICES ON INCORPORATING CHEMOPREVENTION INTO CARE (MiCHOICE)
Protocol | Alliance A191901 |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S0820 |
---|---|
Cancer Type: | Colorectal |
Fast Facts |
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
Protocol | WF 1806 |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | WF 1802 |
---|---|
Cancer Type: | Prostate Cancer |
Fast Facts |
Influence of Primary Treatment for Prostate Cancer on Work Experience (PCW)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EAQ172 |
---|---|
Cancer Type: | Pneumonitis |
Fast Facts |
Optimizing Immunosuppression for Steroid-Refractory Anti-PD-1/PD-L1 Pneumonitis
Protocol | NRG CC003 |
---|---|
Cancer Type: | SCLC |
Fast Facts |
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A211901 |
---|---|
Cancer Type: | Rural Cancer Survivors |
Fast Facts |
REACHING RURAL CANCER SURVIVORS WHO SMOKE USING TEXT-BASED CESSATION INTERVENTIONS
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA1151 (TMIST) |
---|---|
Cancer Type: | Screening |
Fast Facts |
Tomosynthesis Mammographic Imaging Screening Trial (TMIST)
Protocol | EA2185 |
---|---|
Cancer Type: | Pancreatic Cyst Surveillance |
Fast Facts |
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs
Protocol | DCP-001 |
---|---|
Cancer Type: | Multisite - Screening |
Use of a Clinical Trial Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)
Protocol | NRG CC005 FORTE |
---|---|
Cancer Type: | Colonoscopy |
Fast Facts |
FORTE (Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A021804 |
---|---|
Cancer Type: | ADVANCED PHEOCHROMOCYTOMA AND PARAGANGLIOMA |
A PROSPECTIVE, MULTI-INSTITUTIONAL PHASE II TRIAL EVALUATING TEMOZOLOMIDE VS. TEMOZOLOMIDE AND OLAPARIB FOR ADVANCED PHEOCHROMOCYTOMA AND PARAGANGLIOMA
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A021602 |
---|---|
Cancer Type: | Neuroendocrine |
Fast Facts |
RANDOMIZED, DOUBLE-BLINDED PHASE III STUDY OF CABOZANTINIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED NEUROENDOCRINE TUMORS AFTER PROGRESSION ON PRIOR THERAPY (CABINET)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S2001 |
---|---|
Cancer Type: | Metastatic Pancreatic |
Fast Facts |
Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib Alone as Maintenance Therapy in Metastatic Pancreatic Cancer Patients with Germline BRCA1 or BRCA2 Mutations.
Protocol | Alliance A021806 |
---|---|
Cancer Type: | RESECTABLE PANCREATIC CANCER |
Fast Facts |
A PHASE III TRIAL OF PERIOPERATIVE VERSUS ADJUVANT CHEMOTHERAPY FOR RESECTABLE PANCREATIC CANCER
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1922 |
---|---|
Cancer Type: | Small bowel Adenocarcinoma |
Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA2186 |
---|---|
Cancer Type: | Metastatic Pancreatic |
Fast Facts |
A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Naïve Metastatic Pancreatic Cancer (GIANT)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A021502 |
---|---|
Cancer Type: | Colon Cancer |
Fast Facts |
Randomized Trial of Standard Chemotherapy Alone or Combined With Atezolizumab as Adjuvant Therapy for Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair (ATOMIC: Adjuvant Trial of Deficient Mismatch Repair in Colon Cancer)
Protocol | NRG GI005 |
---|---|
Cancer Type: | Stage IIA Colon Cancer |
Fast Facts |
Phase II/III Study of Circulating tumOr DNA as a Predictive BiomaRker in Adjuvant Chemotherapy in Patients with Stage IIA Colon Cancer (COBRA)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A021703 |
---|---|
Cancer Type: | metastatic colorectal cancer |
Fast Facts |
Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)
Protocol | NRG GI004 |
---|---|
Cancer Type: | Colorectal Cancer |
Fast Facts |
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Deficient DNA Mismatch Repair (dMMR) Metastatic Colorectal Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA2182 |
---|---|
Cancer Type: | Early Stage Anal Squamous Cell Carcinoma |
Fast Facts |
A Randomized Phase II Study of De-intensified Chemoradiation for Early Stage Anal Squamous Cell Carcinoma (DECREASE)
Protocol | EA2176 |
---|---|
Cancer Type: | treatment-naïve metastatic anal cancer |
Fast Facts |
A Phase III Study of Immune checkpoint inhibition with chemotherapy in treatment-naïve metastatic anal cancer patients
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA2187 |
---|---|
Cancer Type: | Advanced Intrahepatic Cholangiocarinoma |
Fast Facts |
A Phase II Study of Pevonedistat in Combination with Carboplatin and Paclitaxel in Advanced Intrahepatic Cholangiocarcinoma
Protocol | EA2197 |
---|---|
Cancer Type: | Incidental Gallbladder Cancer |
Fast Facts |
Optimal Perioperative Therapy for Incidental Gallbladder Cancer (OPT-IN)- A Randomized Phase II/III Trial
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA2183 |
---|---|
Cancer Type: | Esophageal and Gastric Adenocarcinoma |
Fast Facts |
A Phase III Study of Consolidative Radiotherapy in Patients with Oligometastatic Esophageal and Gastric Adenocarcinoma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | PDM 9846 |
---|---|
Cancer Type: | Tissue Procurement |
Fast Facts |
Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S0820 |
---|---|
Cancer Type: | Colorectal |
Fast Facts |
A Double Blind Placebo-Controlled Trial of Eflornithine and Sulindac to Prevent Recurrence of High Risk Adenomas and Second Primary Colorectal Cancers in Patients With Stage 0-III Colon or Rectal Cancer, Phase III - Preventing Adenomas of the Colon With Eflornithine and Sulindac (PACES)
Protocol | WF 1806 |
---|---|
Cancer Type: | Cancer Control |
Fast Facts |
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults with Colorectal Cancer: The M&M Study
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA2185 |
---|---|
Cancer Type: | Pancreatic Cyst Surveillance |
Fast Facts |
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A031702 |
---|---|
Cancer Type: | rare genitourinary tumors |
Phase II Study of Cabozantinib in Combination with Nivolumab and Ipilimumab in Rare Genitourinary Tumors
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG GU002 |
---|---|
Cancer Type: | Prostate |
Fast Facts |
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy with or Without Adjuvant Docetaxel
Protocol | NRG GU005 |
---|---|
Cancer Type: | Prostate Cancer |
Fast Facts |
Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Protocol | SWOG S1802 |
---|---|
Cancer Type: | Metastatic Prostate Cancer |
Fast Facts |
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Protocol | EA8171 |
---|---|
Cancer Type: | Prostate Cancer |
Fast Facts |
Multiparametric MRI (mpMRI) for Preoperative Staging and Treatment Planning for Newly-Diagnosed Prostate Cancer
Protocol | NRG GU009 |
---|---|
Cancer Type: | HIGH RISK PROSTATE CANCER |
Fast Facts |
PARALLEL PHASE III RANDOMIZED TRIALS FOR HIGH RISK PROSTATE CANCER EVALUATING DE-INTENSIFICATION FOR LOWER GENOMIC RISK AND INTENSIFICATION OF CONCURRENT THERAPY FOR HIGHER GENOMIC RISK WITH RADIATION (PREDICT-RT*)
Protocol | NRG GU010 |
---|---|
Cancer Type: | Prostate Cancer |
Fast Facts |
NRG-GU010 - Parallel Phase III Randomized Trials of Genomic Risk Stratified Unfavorable Intermediate Risk Prostate Cancer: De-Intensification and Intensification Clinical Trial Evaluation (GUIDANCE)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1931 |
---|---|
Cancer Type: | METASTATIC RENAL CELL CARCINOMA |
Fast Facts |
PHASE III TRIAL OF IMMUNOTHERAPY-BASED DRUG COMBINATION THERAPY WITH OR WITHOUT CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA (PROBE TRIAL)
Protocol | Alliance A031704 |
---|---|
Cancer Type: | METASTATIC UNTREATED RENAL CELL |
Fast Facts |
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib with Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell Cancer [PDIGREE] |
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A031803 |
---|---|
Cancer Type: | BCG-Unresponsive Non Muscle Invasive Bladder |
Fast Facts |
Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Protocol | SWOG S1806 |
---|---|
Cancer Type: | Bladder Cancer |
Fast Facts |
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab In Localized Muscle Invasive Bladder Cancer
Protocol | SWOG S1937 |
---|---|
Cancer Type: | Metastatic Urothelial Carcinoma |
Fast Facts |
A Phase III Randomized Trial of Eribulin (NSC #707389) with or without Gemcitabine versus Standard of Care (Physician’s Choice) for Treatment of Metastatic Urothelial Carcinoma Refractory to, or Ineligible for, Anti PD1/PDL1 Therapy
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A031102 |
---|---|
Cancer Type: | Germ Cell Tumor |
Fast Facts |
A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors
Protocol | SWOG S1823 |
---|---|
Cancer Type: | Newly Diagnosed Germ Cell Tumors |
Fast Facts |
A Prospective Observational Cohort Study to Assess miRNA 371 for Outcome Prediction in Patients With Newly Diagnosed Germ Cell Tumors
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | WF 1802 |
---|---|
Cancer Type: | Prostate Cancer |
Fast Facts |
Influence of Primary Treatment for Prostate Cancer on Work Experience (PCW)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG CC007CD |
---|---|
Cancer Type: | Prostate Cancer |
Fast Facts |
Increasing the Dose of Survivorship Care Planning In Prostate Cancer Survivors Who Receive Androgen Deprivation Therapy
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1823 |
---|---|
Cancer Type: | Newly Diagnosed Germ Cell Tumors |
Fast Facts |
A Prospective Observational Cohort Study to Assess miRNA 371 for Outcome Prediction in Patients With Newly Diagnosed Germ Cell Tumors
Protocol | Alliance A031102 |
---|---|
Cancer Type: | Germ Cell Tumor |
Fast Facts |
A Randomized Phase III Trial Comparing Conventional-Dose Chemotherapy Using Paclitaxel, Ifosfamide, and Cisplatin (TIP) With High-Dose Chemotherapy Using Mobilizing Paclitaxel Plus Ifosfamide Followed by High-Dose Carboplatin and Etoposide (TI-CE) as First Salvage Treatment in Relapsed or Refractory Germ Cell Tumors
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG GY024 |
---|---|
Cancer Type: | Vulvar Cancer |
Fast Facts |
Groningen International Study on Sentinel Nodes in Vulvar Cancer III (GROINSS-V III), a prospective phase II treatment trial
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG CC008 |
---|---|
Cancer Type: | Ovarian Cancer Among BRCA1 Carriers |
Fast Facts |
A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]
Protocol | NRG GY019 |
---|---|
Cancer Type: | Carcinoma of the Ovary or Peritoneum |
Fast Facts |
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG GY006 |
---|---|
Cancer Type: | GYN-newly diagnosed, bulky stage |
Fast Facts |
A Randomized Phase III Trial of Radiation Therapy and Cisplatin Alone or in Combination With Intravenous Triapine in Women With Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG GY018 |
---|---|
Cancer Type: | ENDOMETRIAL CANCER |
Fast Facts |
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA3132 |
---|---|
Cancer Type: | Head and Neck |
Fast Facts |
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG HN001 |
---|---|
Cancer Type: | Nasopharyngeal Carcinoma |
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1701 |
---|---|
Cancer Type: | Thymic Carcinoma |
A Randomized Phase II Trial of Carboplatin-Paclitaxel with or Without Ramucirumab in Patients with Unresectable Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA3161 |
---|---|
Cancer Type: | HPV Positive OPCA |
Fast Facts |
A Phase II/III Randomized Study of Maintenance Nivolumab versus Observation in Patients with Locally Advanced, Intermediate Risk HPV Positive OPCA
Protocol | NRG HN004 |
---|---|
Cancer Type: | Locoregionally Advanced Head and Neck Cancer |
Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin
Protocol | NRG HN005 |
---|---|
Cancer Type: | Oropharyngeal Cancer |
Fast Facts |
A Randomized Phase II/III Trial of De-intensified Radiation Therapy for Patients with Early-Stage, p16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Protocol | RTOG 1216 |
---|---|
Cancer Type: | Pathologic High-Risk Squamous Cell Cancer |
Fast Facts |
Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Protocol | EA3163 |
---|---|
Cancer Type: | Nasal and Paranasal Sinus Squamous Cell Carcinoma |
Phase II Randomized Trial of Neo-Adjuvant Chemo f/b Surgery and Post-Op Radiation vs Surgery and Post-Op Radiation for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma (NPNSCC)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A041501 |
---|---|
Cancer Type: | NEWLY DIAGNOSED PRECURSOR B-CELL ALL |
Fast Facts |
A Phase III Trial to Evaluate the Efficacy of the Addition of Inotuzumab Ozogamicin (a Conjugated Anti-CD22 Monoclonal Antibody) to Frontline Therapy in Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A041701 |
---|---|
Cancer Type: | ACUTE MYELOID LEUKEMIA |
Fast Facts |
A Randomized Phase II/III Study of Conventional Chemotherapy +/- Uproleselan (GMI-1271) in Older Adults With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A041702 |
---|---|
Cancer Type: | Chronic Lymphocytic Leukemia (CLL) |
Fast Facts |
A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib Plus Venetoclax and Obinutuzumab in Untreated Older Patients (> 65 YEARS OF AGE) with Chronic Lymphocytic Leukemia (CLL)
Protocol | SWOG S1925 |
---|---|
Cancer Type: | CLL/SLL |
Fast Facts |
RANDOMIZED, PHASE III STUDY OF EARLY INTERVENTION WITH VENETOCLAX AND OBINUTUZUMAB VERSUS DELAYED THERAPY WITH VENETOCLAX AND OBINUTUZUMAB IN NEWLY DIAGNOSED ASYMPTOMATIC HIGH-RISK PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): EVOLVE CLL/SLL STUDY
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1712 |
---|---|
Cancer Type: | Chronic Myeloid Leukemia (CML) |
Fast Facts |
A Randomized Phase II Study of Ruxolitinib (NSC-752295) in Combination with BCR-ABL Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia (CML) Patients with Molecular Evidence of Disease
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NHLBI-MDS |
---|---|
Cancer Type: | Myelodysplastic Syndromes |
Fast Facts |
The National Myelodysplastic Syndromes (MDS) Study
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG LU006 |
---|---|
Cancer Type: | MALIGNANT PLEURAL MESOTHELIOMA |
PHASE III RANDOMIZED TRIAL OF PLEURECTOMY/DECORTICATION PLUS
CHEMOTHERAPY WITH ORWITHOUT ADJUVANT HEMITHORACIC
INTENSITY-MODULATED PLEURAL RADIATION THERAPY (IMPRINT)
FOR MALIGNANT PLEURAL MESOTHELIOMA (MPM)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | ECOG E4512 |
---|---|
Cancer Type: | Non-Small Cell Lung |
Fast Facts |
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
A substudy of ALCHEMIST A151216
Protocol | EA5162 |
---|---|
Cancer Type: | Advanced NSCLC |
Fast Facts |
Phase II Study of AZD9291 (Osimertinib) in Advanced NSCLC Patients with Exon 20 Insertion Mutations in EGFR
Protocol | EA5163 |
---|---|
Cancer Type: | Non-Small Cell Lung Cancer (NSCLC) |
Fast Facts |
A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature-driven Analysis
Protocol | EA5181 |
---|---|
Cancer Type: | NSCLC |
Fast Facts |
Randomized Phase III Trial of MEDI4736 (durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresectable Stage 3 NSCLC
Protocol | NRG LU002 |
---|---|
Cancer Type: | METASTATIC NON-SMALL CELL LUNG CANCER |
Fast Facts |
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Protocol | SWOG S1914 |
---|---|
Cancer Type: | Early Stage NSCLC |
Fast Facts |
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
Protocol | Alliance A081801 |
---|---|
Cancer Type: | resected NSCLC |
Fast Facts |
Integration of immunotherapy into adjuvant therapy for resected NSCLC: ALCHEMIST chemo-IO
Protocol | SWOG S1900E |
---|---|
Cancer Type: | NS NSCLC |
Fast Facts |
A Phase II Study of AMG 510 in Participants with Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN Lung-MAP Sub-Study
Protocol | EA5191 |
---|---|
Cancer Type: | NSCLC |
Fast Facts |
A Randomized Phase II Trial of Cabozantinib and Cabozantinib Plus Nivolumab Versus Standard Chemotherapy in Patients with Previously Treated Non-Squamous NSCLC
Protocol | Alliance A171901 |
---|---|
Cancer Type: | Older Non-Small Lung Cancer |
Fast Facts |
Older Non-Small Lung Cancer Patients (>/= 70 Years of Age) Treated with First-Line MK-3475 (Pembrolizumab) +/- Chemotherapy (Oncologist’s/Patient’s Choice)
Protocol | SWOG S1800D |
---|---|
Cancer Type: | Stage IV or Recurrent Non-Small Cell Lung Cancer |
Fast Facts |
A Phase 11/111 Study of N-803 (ALT-803) plus Pembrolizumab versus Standard of Care in Participants with Stage IV or Recurrent Non-Small Cell Lung Cancer Previously Treated with Anti-PD-1 or Anti-PD-L 1 Therapy (Lung-MAP Non-Match Sub-Study)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG CC003 |
---|---|
Cancer Type: | SCLC |
Fast Facts |
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Protocol | NRG LU005 |
---|---|
Cancer Type: | Limited Stage Small Cell Lung Cancer |
Fast Facts |
Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
Protocol | SWOG S1827 |
---|---|
Cancer Type: | Small Cell Lung |
Fast Facts |
MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)
Protocol | NRG LU007 |
---|---|
Cancer Type: | ES-SCLC |
Fast Facts |
RAndomized Phase II/III Trial Of Consolidation Radiation + Immuno-therapy for ES-SCLC: RAPTOR trial
Protocol | SWOG S1929 |
---|---|
Cancer Type: | ES-SCLC |
Fast Facts |
Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab in Combination with Talazoparib in Patients with SLFN11 Positive Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | PDM 9846 |
---|---|
Cancer Type: | Tissue Procurement |
Fast Facts |
Patient-Derived Models Tissue Procurement Protocol for the National Cancer Institute (NCI)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A151216 |
---|---|
Cancer Type: | Non-Small Cell Lung |
Fast Facts |
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Sub-Studies to ALCHEMIST: A081105, E4512 and EA5142
Protocol | LUNG MAP |
---|---|
Cancer Type: | NSCLC |
Fast Facts |
A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A051301 |
---|---|
Cancer Type: | Lymphoma |
Fast Facts |
A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma of the Activated B-Cell Subtype
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1925 |
---|---|
Cancer Type: | CLL/SLL |
Fast Facts |
RANDOMIZED, PHASE III STUDY OF EARLY INTERVENTION WITH VENETOCLAX AND OBINUTUZUMAB VERSUS DELAYED THERAPY WITH VENETOCLAX AND OBINUTUZUMAB IN NEWLY DIAGNOSED ASYMPTOMATIC HIGH-RISK PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): EVOLVE CLL/SLL STUDY
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A051701 |
---|---|
Cancer Type: | Double-hit and double-expressing lymphomas |
Fast Facts |
Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas |
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1608 |
---|---|
Cancer Type: | FOLLICULAR LYMPHOMA |
Fast Facts |
Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA4181 |
---|---|
Cancer Type: | Untreated Mantle Cell lymphoma |
Fast Facts |
A Randomized 3-Arm Phase II Study Comparing 1.) Bendamustine, Rituximab and High Dose Cytarabine (BR/CR) 2.) Bendamustine, Rituximab, High Dose Cytarabine and Acalabrutinib (BR/CR-A), and 3.) Bendamustine, Rituximab and Acalabrutinib (BR-A) in Patients <70 years old with Untreated Mantle Cell Lymphoma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1826 |
---|---|
Cancer Type: | ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA |
Fast Facts |
A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | TAPUR |
---|---|
Cancer Type: | Multisite |
Fast Facts |
Targeted Agent and Profiling Utilization Registry (TAPUR) Study
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | 10323 Moonshot |
---|---|
Cancer Type: | Biospecimen |
Fast Facts |
Cancer Moonshot Biobank Research Protocol
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EAY131 - MATCH |
---|---|
Cancer Type: | Molecular |
Fast Facts |
Molecular Analysis for Therapy Choice (MATCH)
Protocol | SWOG S1609 DART |
---|---|
Cancer Type: | Rare Tumors |
Fast Facts |
DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
Protocol | EAY131 - MATCH Protocol Z1M |
---|---|
Cancer Type: | Molecular |
Fast Facts |
Phase 2 Study of Nivolumab and BMS-986016 (Relatlimab) in Patients with LAG-3+ Tumors with Mismatch Repair Deficiency (MMR-d) after Progression on Anti-PD-1/PD-L1 Therapy
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A231601CD |
---|---|
Cancer Type: | CCDR |
Fast Facts |
Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | DCP-001 |
---|---|
Cancer Type: | Multisite - Screening |
Use of a Clinical Trial Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EAY131 - MATCH Protocol H |
---|---|
Cancer Type: | Molecular |
Fast Facts |
Molecular Analysis for Therapy Choice (MATCH): MATCH Treatment Subprotocol H: EAY131-H: Phase II Study of Dabrafenib and Trametinib in Patients with Tumors with BRAF V600E or V600K Mutations (Excluding Melanoma and Thyroid Cancer)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EAA181 |
---|---|
Cancer Type: | Newly diagnosed Multiple Myeloma |
Fast Facts |
Effective Quadruplet Utilization After Treatment Evaluation (EQUATE): A Randomized Phase 3 Trial for Newly Diagnosed Multiple Myeloma Not Intended for Early Autologous Transplantation
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EAA173 |
---|---|
Cancer Type: | Smoldering Myeloma |
Fast Facts |
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1803 |
---|---|
Cancer Type: | Multiple Myeloma |
Fast Facts |
Phase III Study of Daratumumab/rHuPH20 (NSC-810307) + Lenalidomide or Lenalidomide as Post-Autologous Stem Cell Transplant Maintenance Therapy in Patients with Multiple Myeloma (MM) Using Minimal Residual Disease to Direct Therapy Duration (DRAMMATIC Study)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EAA171 |
---|---|
Cancer Type: | Myeloma - MRD Assessment |
Fast Facts |
Optimizing Prolonged Treatment In Myeloma Using MRD Assessment (OPTIMUM)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A091902 |
---|---|
Cancer Type: | ANGIOSARCOMA |
A MULTICENTER PHASE II TRIAL OF PACLITAXEL WITH AND WITHOUT NIVOLUMAB IN TAXANE NAÏVE, AND NIVOLUMAB AND CABOZANTINIB IN TAXANE PRETREATED SUBJECTS WITH ANGIOSARCOMA
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A021804 |
---|---|
Cancer Type: | ADVANCED PHEOCHROMOCYTOMA AND PARAGANGLIOMA |
A PROSPECTIVE, MULTI-INSTITUTIONAL PHASE II TRIAL EVALUATING TEMOZOLOMIDE VS. TEMOZOLOMIDE AND OLAPARIB FOR ADVANCED PHEOCHROMOCYTOMA AND PARAGANGLIOMA
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1706 |
---|---|
Cancer Type: | Inflammatory Breast Cancer |
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently with Radiotherapy versus Radiotherapy Alone for Inflammatory Breast Cancer
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | SWOG S1922 |
---|---|
Cancer Type: | Small bowel Adenocarcinoma |
Randomized Phase II Selection Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A031702 |
---|---|
Cancer Type: | rare genitourinary tumors |
Phase II Study of Cabozantinib in Combination with Nivolumab and Ipilimumab in Rare Genitourinary Tumors
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA3163 |
---|---|
Cancer Type: | Nasal and Paranasal Sinus Squamous Cell Carcinoma |
Phase II Randomized Trial of Neo-Adjuvant Chemo f/b Surgery and Post-Op Radiation vs Surgery and Post-Op Radiation for Organ Preservation of T3 and T4a Nasal and Paranasal Sinus Squamous Cell Carcinoma (NPNSCC)
Protocol | SWOG S1701 |
---|---|
Cancer Type: | Thymic Carcinoma |
A Randomized Phase II Trial of Carboplatin-Paclitaxel with or Without Ramucirumab in Patients with Unresectable Locally Advanced, Recurrent, or Metastatic Thymic Carcinoma
Protocol | NRG HN001 |
---|---|
Cancer Type: | Nasopharyngeal Carcinoma |
Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)
Protocol | NRG HN004 |
---|---|
Cancer Type: | Locoregionally Advanced Head and Neck Cancer |
Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Locoregionally Advanced Head and Neck Cancer with a Contraindication to Cisplatin
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | NRG LU006 |
---|---|
Cancer Type: | MALIGNANT PLEURAL MESOTHELIOMA |
PHASE III RANDOMIZED TRIAL OF PLEURECTOMY/DECORTICATION PLUS
CHEMOTHERAPY WITH ORWITHOUT ADJUVANT HEMITHORACIC
INTENSITY-MODULATED PLEURAL RADIATION THERAPY (IMPRINT)
FOR MALIGNANT PLEURAL MESOTHELIOMA (MPM)
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A091902 |
---|---|
Cancer Type: | ANGIOSARCOMA |
A MULTICENTER PHASE II TRIAL OF PACLITAXEL WITH AND WITHOUT NIVOLUMAB IN TAXANE NAÏVE, AND NIVOLUMAB AND CABOZANTINIB IN TAXANE PRETREATED SUBJECTS WITH ANGIOSARCOMA
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | COG AOST2031 |
---|---|
Cancer Type: | Osteosarcoma |
Fast Facts |
COG AOST2031
A Phase 3 Randomized Controlled Trial Comparing Open vs Thoracoscopic Management of Pulmonary Metastases in Patients with Osteosarcoma
Patients must be < 50 years at the time of enrollment
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | ECOG EA6141 |
---|---|
Cancer Type: | Melanoma-unresectable |
Fast Facts |
Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma
Protocol | EA6192 |
---|---|
Cancer Type: | Advanced Melanoma |
Fast Facts |
A Phase II Study of Biomarker Driven Early Discontinuation of anti-PD-1 Therapy in Patients with Advanced Melanoma (PET-Stop)
Protocol | SWOG S2000 |
---|---|
Cancer Type: | Melanoma with Brain Metastases |
Fast Facts |
A Randomized Phase 2 Trial Of Encorafenib + Binimetinib + Nivolumab Vs Ipilimumab + Nivolumab In Brafv600-Mutant Melanoma with Brain Metastases
Protocol | EA6194 |
---|---|
Cancer Type: | Operable Melanoma |
Fast Facts |
Phase II Randomized Study of Neoadjuvant Pembrolizumab Alone or in Combination with CMP-001 in Patients with Operable Melanoma: Efficacy and Biomarker Study
Protocol | SWOG S2015 |
---|---|
Cancer Type: | primary cutaneous melanoma |
Fast Facts |
Melanoma Margins Trial (MelMarT-II): A Phase III, multi-centre, multi-national randomised control trial investigating 1cm v 2cm wide excision margins for primary cutaneous melanoma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | EA6174 |
---|---|
Cancer Type: | Merkel Cell Carcinoma |
Fast Facts |
A Phase III Randomized Trial Comparing Adjuvant MK-3475 (Pembrolizumab) to Standard of Care Observation in Completely Resected Merkel Cell Carcinoma
Please check out the rare protocol list to locate other studies within this disease site.
Protocol | Alliance A091802 |
---|---|
Cancer Type: | Carcinoma of the Skin |
Fast Facts |
Phase II Randomized Trial of Avelumab Plus Cetuximab Versus Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma of the Skin
Please check out the rare protocol list to locate other studies within this disease site.
Cancer clinical trials are research studies for developing better ways of detecting,
treating, and eventually preventing cancer. By taking part in a clinical trial,
you are among the first to receive new research treatments before they are widely
available. Your participation in a clinical trial will influence the future direction
of cancer care.
If you are interested in participating in a clinical trial, consult with your physician.
Please note: clinical trials are not risk free. Patients must explore the options
that are best for their individuals needs with the help of their physician.